Safety and immunogenicity of the epicutaneous reactivation of pertussis toxin immunity in healthy adults: a phase I, randomized, double-blind, placebo-controlled trial
- Chatzis, Olga
- Blanchard Rohner, Géraldine
- Mondoulet, L
- Pelletier, B
- De Gea-Hominal, Audrey
- Roux, M
- Csaki Huttner, Angela
- Hervé, P L
- Rohr, M
- Matthey, Alain
- Gutknecht, G
- Lemaitre, Barbara
- Hayem, C
- Pham, H T
- Wijagkanalan, W
- Lambert, Paul Henri
- Benhamou, P H
- Siegrist, Claire-Anne
DOIAbstract
Protection induced by acellular vaccines can be short, requiring novel immunization strategies. Objectives of this study were to evaluate safety and capacity of a recombinant pertussis toxin (PTgen) -coated Viaskin® epicutaneous patch to recall memory responses in healthy adults
Add to ORKG